CVS Health enhances its direct-to-consumer weight management offerings to improve access, affordability, care and support for GLP-1 medications

Summary

CVS Health and Eli Lilly announced a collaboration to enhance access to FDA-approved GLP-1 medications, including Zepbound and Foundayo, through CVS Pharmacy and the MinuteClinic digital platform for eligible patients seeking weight management treatment.